Lista de obras -

23Na MRI longitudinal follow-up of PDT in a xenograft model of human retinoblastoma.

artículo científico publicado en 2009

A Parent-of-Origin Effect Impacts the Phenotype in Low Penetrance Retinoblastoma Families Segregating the c.1981C>T/p.Arg661Trp Mutation of RB1

artículo científico publicado en 2016

A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors

scientific article published on 10 September 2019

A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression

artículo científico publicado en 2021

A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors

artículo científico publicado en 2016

A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: an Innovative Therapies for Children with Cancer (ITCC) study

artículo científico publicado en 2011

Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma

artículo científico publicado en 2009

Another point of view on 2017 PRETEXT

scientific article published on 14 August 2018

Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlation

scientific article published on 30 November 2014

Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma

scientific article published on 18 June 2020

Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends ⬇️

artículo científico publicado el 27 de enero de 2012

Combination of Carboplatin and Bevacizumab Is an Efficient Therapeutic Approach in Retinoblastoma Patient-Derived Xenografts

artículo científico publicado en 2016

Conservative treatments of intraocular retinoblastoma.

artículo científico publicado en 2008

Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy

artículo científico publicado en 2018

Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis

artículo científico publicado en 2020

EPT-07PARTICIPATION OF CHILDREN AND ADOLESCENTS WITH CENTRAL NERVOUS SYSTEM TUMOURS IN PHASE I TRIALS WITHIN THE ITCC EUROPEAN CONSORTIUM.

artículo científico publicado en 2016

EPT-13RAPIRI I – PHASE I STUDY OF DAILY ORAL RAPAMYCIN AND INTRAVENOUS IRINOTECAN IN CHILDREN WITH A RECURRENT/REFRACTORY MALIGNANT SOLID TUMOR: GOOD TOLERANCE AND PROMISING RESULTS IN BRAIN TUMORS - A REPORT FROM THE SOCIÉTÉ FRANÇAISE DES CANCERS E

artículo científico publicado en 2016

Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary

artículo científico publicado en 2003

Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut Curie.

artículo científico publicado en 2018

Establishment of an Orthotopic Xenograft Mice Model of Retinoblastoma Suitable for Preclinical Testing

artículo científico publicado en 2015

Eye Salvage with Combination of Intravitreal and Intracameral Melphalan Injection for Recurrent Retinoblastoma with Anterior Chamber Involvement: Report of a Case

artículo científico publicado en 2016

Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors.

artículo científico publicado en 2016

Fine mapping of whole RB1 gene deletions in retinoblastoma patients confirms PCDH8 as a candidate gene for psychomotor delay

artículo científico publicado en 2012

Fine needle aspiration in the diagnosis and classification of hepatoblastoma: Analysis of 21 New Cases

scientific article published on 09 December 2016

Hypercalcemia and childhood cancer: a 7-year experience.

artículo científico publicado en 2005

Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

scientific article published on 09 October 2020

In vivo efficacy of photodynamic therapy in three new xenograft models of human retinoblastoma

artículo científico publicado en 2010

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

artículo científico publicado en 2010

LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB

Looking for the Most Suitable Orthotopic Retinoblastoma Mouse Model in Order to Characterize the Tumoral Development.

artículo científico publicado en 2017

MDM2 as a modifier gene in retinoblastoma

artículo científico publicado en 2010

Management of advanced uni- or bilateral retinoblastoma with macroscopic optic nerve invasion

artículo científico publicado en 2019

Metastatic neuroblastoma in a patient with ROHHAD: A new alert regarding the risk of aggressive malignancies in this rare condition

scientific article published on 16 July 2019

Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial

scholarly article by Arnauld Verschuur et al published 2018 in Frontiers in Pharmacology

Mosaicism and prenatal diagnosis options: insights from retinoblastoma

artículo científico publicado en 2016

Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?

artículo científico publicado en 2019

Outcome of children and adolescents with central nervous system tumors in phase I trials.

artículo científico publicado en 2017

Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie.

artículo científico publicado en 2004

Parents' and children's comprehension and decision in a paediatric early phase oncology trial: a prospective study

scientific article published on 24 November 2018

Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours

artículo científico

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

artículo científico publicado en 2018

Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma

artículo científico publicado en 2015

Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma

artículo científico publicado en 2017

Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours

artículo científico publicado en 2010

Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma

artículo científico publicado en 2020

Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

artículo científico publicado en 2010

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

artículo científico publicado en 2013

Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study

artículo científico publicado en 2019

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study.

artículo científico publicado en 2013

Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma

artículo científico publicado en 2011

Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study.

artículo científico publicado en 2016

Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome

scientific article published on 24 October 2020

Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection

artículo científico

Reiterative Radiofrequency Ablation in the Management of Pediatric Patients with Hepatoblastoma Metastases to the Lung, Liver, or Bone

article

Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison.

artículo científico publicado en 2007

Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation

artículo científico publicado en 2013

Retinoblastoma

artículo científico publicado en 2006

Retinoblastoma: Update on Current Management.

artículo científico publicado en 2017

Retinoblastoma: recent advances

artículo científico publicado en 2014

Retinoblastoma: systematic removal in cases of white pupillary reflection or strabismus

artículo científico publicado en 2007

SFCE METRO-01 four-drug metronomic regimen phase II trial for pediatric extracranial tumor

artículo científico publicado en 2019

SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers

artículo científico publicado en 2020

Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomes

artículo científico publicado en 2013

The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletion

artículo científico publicado en 2014

The transmanubrial approach: A new operative approach to cervicothoracic neuroblastoma in children

artículo científico publicado en 2006

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

artículo científico publicado en 2019

Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission

artículo científico publicado en 2012

Tumor rupture in hepatoblastoma: A high risk factor?

artículo científico publicado en 2020

Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndrome

artículo científico publicado en 2014

[Childhood cancer: progress but prognosis still very unequal. Example of Retinoblastoma and high-risk Neuroblastoma]

artículo científico publicado en 2014

Lista de obras de

23Na MRI longitudinal follow-up of PDT in a xenograft model of human retinoblastoma.

A Parent-of-Origin Effect Impacts the Phenotype in Low Penetrance Retinoblastoma Families Segregating the c.1981C>T/p.Arg661Trp Mutation of RB1

A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid Tumors

A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression

A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors

A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: an Innovative Therapies for Children with Cancer (ITCC) study

Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma

Another point of view on 2017 PRETEXT

Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlation

Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma

Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends ⬇️

Combination of Carboplatin and Bevacizumab Is an Efficient Therapeutic Approach in Retinoblastoma Patient-Derived Xenografts

Conservative treatments of intraocular retinoblastoma.

Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy

Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis

EPT-07PARTICIPATION OF CHILDREN AND ADOLESCENTS WITH CENTRAL NERVOUS SYSTEM TUMOURS IN PHASE I TRIALS WITHIN THE ITCC EUROPEAN CONSORTIUM.

EPT-13RAPIRI I – PHASE I STUDY OF DAILY ORAL RAPAMYCIN AND INTRAVENOUS IRINOTECAN IN CHILDREN WITH A RECURRENT/REFRACTORY MALIGNANT SOLID TUMOR: GOOD TOLERANCE AND PROMISING RESULTS IN BRAIN TUMORS - A REPORT FROM THE SOCIÉTÉ FRANÇAISE DES CANCERS E

Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary

Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut Curie.

Establishment of an Orthotopic Xenograft Mice Model of Retinoblastoma Suitable for Preclinical Testing

Eye Salvage with Combination of Intravitreal and Intracameral Melphalan Injection for Recurrent Retinoblastoma with Anterior Chamber Involvement: Report of a Case

Feasibility and clinical integration of molecular profiling for target identification in pediatric solid tumors.

Fine mapping of whole RB1 gene deletions in retinoblastoma patients confirms PCDH8 as a candidate gene for psychomotor delay

Fine needle aspiration in the diagnosis and classification of hepatoblastoma: Analysis of 21 New Cases

Hypercalcemia and childhood cancer: a 7-year experience.

Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

In vivo efficacy of photodynamic therapy in three new xenograft models of human retinoblastoma

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB

Looking for the Most Suitable Orthotopic Retinoblastoma Mouse Model in Order to Characterize the Tumoral Development.

MDM2 as a modifier gene in retinoblastoma

Management of advanced uni- or bilateral retinoblastoma with macroscopic optic nerve invasion

Metastatic neuroblastoma in a patient with ROHHAD: A new alert regarding the risk of aggressive malignancies in this rare condition

Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial

Mosaicism and prenatal diagnosis options: insights from retinoblastoma

Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?

Outcome of children and adolescents with central nervous system tumors in phase I trials.

Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie.

Parents' and children's comprehension and decision in a paediatric early phase oncology trial: a prospective study

Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma

Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma

Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours

Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma

Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study.

Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma

Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study.

Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome

Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection

Reiterative Radiofrequency Ablation in the Management of Pediatric Patients with Hepatoblastoma Metastases to the Lung, Liver, or Bone

Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: a retrospective study of 150 patients with histological comparison.

Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation

Retinoblastoma

Retinoblastoma: Update on Current Management.

Retinoblastoma: recent advances

Retinoblastoma: systematic removal in cases of white pupillary reflection or strabismus

SFCE METRO-01 four-drug metronomic regimen phase II trial for pediatric extracranial tumor

SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers

Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomes

The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletion

The transmanubrial approach: A new operative approach to cervicothoracic neuroblastoma in children

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission

Tumor rupture in hepatoblastoma: A high risk factor?

Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndrome

[Childhood cancer: progress but prognosis still very unequal. Example of Retinoblastoma and high-risk Neuroblastoma]